66 participants
Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-01
- Start Date:
- 2026-06-16
- Completion:
- 2029-12-31
Conditions
- DLBCL - Diffuse Large B Cell Lymphoma
Interventions
- DRUG
No Results Yet